Clinical Trial Update: A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase 1 clinical trial update on a chemogenetics therapy for Parkinson's disease, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Chemogenetics Therapy
• Clozapine (Clozapine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Parkinson Disease (PD), Gene Therapy | EARLY_Phase 1 | Status: NOT_YET_RECRUITING